FR3023165A1 - DEVICE APPLYING A NEW TECHNIQUE FOR TREATING BACTERIAL FIREFIGHTER WITH TWO SIMULTANEOUSLY APPLIED THERMAL ENTHALPY ABSORPTIONS AND DEHYDRATION - Google Patents

DEVICE APPLYING A NEW TECHNIQUE FOR TREATING BACTERIAL FIREFIGHTER WITH TWO SIMULTANEOUSLY APPLIED THERMAL ENTHALPY ABSORPTIONS AND DEHYDRATION Download PDF

Info

Publication number
FR3023165A1
FR3023165A1 FR1401580A FR1401580A FR3023165A1 FR 3023165 A1 FR3023165 A1 FR 3023165A1 FR 1401580 A FR1401580 A FR 1401580A FR 1401580 A FR1401580 A FR 1401580A FR 3023165 A1 FR3023165 A1 FR 3023165A1
Authority
FR
France
Prior art keywords
dehydration
absorptions
simultaneously applied
new technique
firefighter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR1401580A
Other languages
French (fr)
Inventor
Alain Salou
Alexandre Salou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR1401580A priority Critical patent/FR3023165A1/en
Publication of FR3023165A1 publication Critical patent/FR3023165A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Dispositif appliquant une nouvelle technique de traitement de tumeurs (5), de foyer bactériens résistants, par deux absorptions appliquées simultanément l'une par enthalpie thermique l'autre par déshydratation asséchant les cellules malignes (7), provoquant ainsi une nécrose ischémique des cellules tumorales.Device applying a new technique for the treatment of tumors (5), resistant bacterial focus, by two absorptions simultaneously applied one by thermal enthalpy the other by dehydration drying malignant cells (7), thereby causing ischemic necrosis of tumor cells .

Description

02 3 16 5 La présente invention concerne une solution technique nouvelle à un problème de santé publique un dispositif ,permettant de traiter en dé-ambulatoire en lieu et place de solutions chirurgicales traditionnelles agressives , les cancers localisés , les zones localisées infectées de bactéries récidivantes , par injection d'un liquide à très basse 5 température dans une tumeur maligne une zone tumorale ou une zone infectée . Le traitement des tumeurs malignes est traditionnellement effectué par une intervention chirurgicale , avec en complément de la chimiothérapie , des rayons ionisants , des capsules de Curie , les micros ondes , les inducteurs à plasma , le rayonnement gamma avec source au cobalt , les lasers infra rouge avec leur incertitude 10 sur les azimuts de tirs et les diffractions spécifiques à ces différentes méthodes , cryothérapie par aiguilles à circulation d'argon ou autres gaz avec risques ce givrage , formation d'une boule de glace à l'extrémité de l'aiguille creuse et d'arrachement des zones traversées au retrait , toutes ces méthodes nécessitent des investissements lourds , onéreux , une mise en oeuvre délicate complexe , la présence de plusieurs 15 intervenants . Le dispositif selon l'invention permet de remédier à ces inconvénients en effet sa mise en oeuvre est simple , appliquant simultanément deux principes de la physique ,dans un premier temps , la mise en froid destructrice par absorption thermique localisée avec expansion contenue par une couche barrière de glace létale 20 isolant la tumeur et faisant éclater les capillaires (1) ( néo-vaisseaux) alimentant la zone malade (5). Dans un deuxième temps un principe d'absorption hydrophile , de déshydratation intense desséchant les cellules tumorales (3) par éjection de l'eau (11) puis en dénaturant la structure des protéines cellulaires et en dissolvant les lipides . Six ou 25 huit séances d'injections peuvent être nécessaires pour détruire un cancer. Selon le dispositif un liquide (6) de type alcool de la chaîne éthylique antiseptique ,anesthésique type éthanol médical CH3CH2OH , C2H5OH .. d'origine végétale ou de synthèse alcool pur anhydre est injecté à très basse température modulable de -10 °C à -113°C par voie percutané (fig 1) à l'aide d'une aiguille très fine (10) , selon une 30 autre variante en fonction de l'agressivité combattue de la tumeur ciblée , de l'éthanol est propulsé à une température de -114,1 °C à -160 °C dans la tumeur à état solide enthalpique, . Les cellules vivantes se détruisent soit par le chaud soit par le froid , par le chaud il y a souvent carbonisation ,les cellules disparaissent , par le froid il y a absorption de 35 la chaleur latente ( enthalpique , cryogénique ) , les cellules gardent leur structure initiale il y a formation d'une couche de glace létale périphérique (4) à la tumeur qui fait exploser les néo-vaisseaux (1) ( capillaires alimentant les cellules malignes) , la glace apparaissant dans ces petits vaisseaux provoquant une coagulation , les capillaires auront cessé d'alimenter les cellules malades (3). La tumeur à traiter 40 baignera alors dans un bain liquide prisonnière de la barrière périphérique de glace létale (4) avec gradient thermique croissant vers l'extérieur bloquant l'expansion du liquide injecté dans le corps . Dans un deuxième temps la zone maligne (5) isolée du reste du corps par la couche de glace létale résiduelle (4) , l'éthanol pur (6) toujours liquide , (ou type d'alcool de propriétés hydrophiles équivalentes ) , avide d'eau 45 , pompera l'eau (8) des cellules (3) (de la tumeur en éjectant l'eau des cellules tumorales qui seront vidées de leur eau (7) ( en les déshydratant ) en modifiant ,dénaturant ainsi la structure des protéines cellulaires . L'action de déshydratation succédant à l'éclatement des néo-vaisseaux (1), provoquera en finale une thrombose 302 3 16 5 z des capillaires alimentaires , une ischémie , donc la destruction de la tumeur ciblée. Les cellules de zone maligne maintenant asséchées (7) l'alcool éthylique , miscible , chargé de l'eau (8) pompée des cellules attaquées (3) ressortira naturellement au dégonflement de la tumeur par cathéter ou un trocart installé à cet effet . A ce stade l'éthanol sera toujours liquide ,et la couche périphérique de glace létale ( couche barriére ) n'aura pas entiérement n'aura pas totalement disparue ce qui évitera une expansion du liquide frigorigène dans l'organisme facilitera l'évacuation protégeant ainsi les organes de proximité .Au réchauffement le système immunitaire , principalement les globules blancs élimineront les restes de tissus morts , certaines études suggèrent même que cette intervention massive de globules blancs stimulerait le système immunitaire à attaquer les cellules cancéreux résiduelles privées de leur éléments inhibiteur sensibles au froid. En cas de tumeur ayant atteint un trop gros volume , son extraction par voie classique est souvent jugée trop risquée pour le patient par les chirurgiens , le corps humain donc les cellules vivantes (3) étant constitué de 60% d'eau , les propriété déshydratantes de l'éthanol provoquées par l'injection permettront de diminuer le volume de la tumeur jusqu'à une taille opérable jugée possible . L'alcool éthylique utilisé pourra être d'origine naturelle ,( betterave rouge , grenade , cassis polyphénol ...).ou d'origine de synthèse dopé avec des éléments actifs de 20 chimiothérapie , cytokines , agents cytotoxiques ou équivalentes ..). Les dessins annexés illustrent la nouvelle solution technique du dispositif : La figure 1 montre une tumeur (5) avec ses cellules (3) chargées à 60% d'eau ainsi que les néo-vaisseaux (1) capillaires spécifiques alimentant la tumeur . La figure 2 montre l'injection de l'alcool éthylique(6) dans la tumeur par l'aiguille (10) 25 la couche de glace létale qui se forme( 4) et fait éclater en froid intense les néovaisseaux (1). La figure 3 montre , les néo-vaisseaux éclatés (2) , les cellules malignes (7) vidées de leur eau par déshydratation intense au contact de l'éthanol hydrophile , avide d'eau revertant progressivement à la température du corps traité , l'éjection de cet eau (8) 30 mélangée avec l'alcool qui fera alors fonction d'antigel s'échappera de la zone traitée par un cathéter ou un trocart placé à cet effet.Couche de glace résiduelle (9).injection éthanol (6). Bien évidemment le principe objet de la présente invention , n'est nullement limité aux schémas du présent document mais peut s'appliquer à une quelconque mise en oeuvre 35 qui appliquerait successivement ou simultanément le principe du couplage de deux principes de la physique la création d'une couche barrière de glace létale faisant éclater les néo-vaisseaux , la déshydratation par éjection de l'eau des cellules traité,The present invention relates to a new technical solution to a public health problem, a device that makes it possible to treat, in place of traditional aggressive surgical solutions, localized cancers, localized zones infected with recurrent bacteria, by injecting a liquid at a very low temperature into a malignant tumor, a tumor zone or an infected zone. The treatment of malignant tumors is traditionally performed by surgery, in addition to chemotherapy, ionizing radiation, Curie capsules, microwaves, plasma inducers, gamma radiation with cobalt source, infrared lasers with their uncertainty on the shooting azimuths and the diffractions specific to these different methods, cryotherapy using argon-circulation needles or other gases with risks of this icing, formation of an ice ball at the end of the hollow needle and of tearing of the zones crossed to the withdrawal, all these methods require heavy, expensive investments, a complex delicate implementation, the presence of several 15 speakers. The device according to the invention makes it possible to remedy these drawbacks in fact its implementation is simple, simultaneously applying two principles of physics, in a first stage, the destructive cooling by localized thermal absorption with expansion contained by a barrier layer. lethal ice 20 insulating the tumor and bursting the capillaries (1) (neo-vessels) feeding the diseased area (5). In a second step a hydrophilic absorption principle, intense dehydration drying tumor cells (3) by ejection of water (11) and then denaturing the structure of cellular proteins and dissolving lipids. Six to 25 sessions of injections may be required to destroy cancer. According to the device, a liquid (6) of the alcohol type of the antiseptic ethyl chain, anesthetic type medical ethanol CH3CH2OH, C2H5OH. Of plant origin or of synthesis anhydrous pure alcohol is injected at a very low temperature which can be adjusted from -10 ° C. to - 113 ° C. percutaneously (FIG. 1) using a very fine needle (10), according to another variant, depending on the aggressiveness combated by the targeted tumor, ethanol is propelled at a temperature from -114.1 ° C to -160 ° C in the enthalpic solid state tumor,. The living cells are destroyed either by the hot or by the cold, by the heat there is often carbonization, the cells disappear, by the cold there is absorption of the latent heat (enthalpic, cryogenic), the cells keep their structure initial formation of a layer of peripheral lethal ice (4) to the tumor that explodes neo-vessels (1) (capillaries feeding the malignant cells), the ice appearing in these small vessels causing coagulation, the capillaries have stopped feeding the diseased cells (3). The tumor to be treated 40 will then bathe in a liquid bath trapped by the lethal ice peripheral barrier (4) with thermal gradient increasing outward blocking the expansion of the liquid injected into the body. In a second step the malignant zone (5) isolated from the rest of the body by the residual lethal ice layer (4), pure ethanol (6) always liquid, (or type of alcohol with equivalent hydrophilic properties), eager to water 45, will pump the water (8) of the cells (3) (from the tumor by ejecting the water from the tumor cells which will be emptied of their water (7) (by dehydrating them) by modifying, thus denaturing the structure of the Cellular proteins The dehydration action following the bursting of the neovessels (1) will finally cause a thrombosis 302 3 16 5 z of the alimentary capillaries, an ischemia, thus the destruction of the targeted tumor. malignant now dried (7) miscible ethyl alcohol, charged with water (8) pumped from the attacked cells (3) will naturally emerge from the deflation of the tumor by catheter or a trocar installed for this purpose. ethanol will still be liquid, and the channel layer lethal ice (barrier layer) will not have completely disappeared, which will prevent an expansion of the refrigerant in the body will facilitate evacuation thus protecting the local organs. Warming the immune system, mainly the White blood cells will remove the remains of dead tissue, some studies even suggest that this massive intervention of white blood cells would stimulate the immune system to attack residual cancer cells deprived of their cold-sensitive inhibitory elements. In the case of a tumor that has reached too large a volume, its extraction by conventional route is often considered too risky for the patient by the surgeons, the human body thus the living cells (3) consisting of 60% of water, the desiccant properties ethanol caused by the injection will reduce the volume of the tumor to an operable size considered possible. The ethyl alcohol used may be of natural origin (beetroot, pomegranate, blackcurrant polyphenol, etc.) or of synthetic origin doped with active elements of chemotherapy, cytokines, cytotoxic agents or the like. The accompanying drawings illustrate the new technical solution of the device: FIG. 1 shows a tumor (5) with its cells (3) loaded with 60% of water as well as the neo-vessels (1) specific capillaries supplying the tumor. Figure 2 shows the injection of the ethyl alcohol (6) into the tumor by the needle (10) the lethal ice layer that forms (4) and burst in intense cold the neovessels (1). FIG. 3 shows, the exploded neo-vessels (2), the malignant cells (7) drained of their water by intense dehydration in contact with the hydrophilic ethanol, eager for water reverting progressively to the temperature of the treated body, ejection of this water (8) mixed with the alcohol which will then act as anti-freeze will escape from the treated area by a catheter or a trocar placed for this purpose. Residual ice layer (9) ethanol injection (6) ). Obviously the principle of the present invention is not limited to the diagrams of this document but can be applied to any implementation that would successively or simultaneously apply the principle of coupling two principles of physics, the creation of a lethal ice-barrier layer bursting the neo-vessels, dehydration by ejection of treated cell water,

Claims (3)

REVENDICATIONS1. J Composition utilisée pour le traitement des tumeurs malignes (3) ou de zones infectées (5) par des bactéries résistantes , ou certains virus . Caractérisé en ce qu'elle comprend un liquide à base d'alcool éthylique .REVENDICATIONS1. Composition used for treating malignant tumors (3) or infected areas (5) with resistant bacteria, or certain viruses. Characterized in that it comprises a liquid based on ethyl alcohol. 2) Composition selon la revendication (1) caractérisé en ce que le liquide à base d'alcool éthylique soit de l'éthanol type CH3CH2OH , C2H5OH.. de qualité médical anhydre utilisé en anesthésie, injecté à très basse température .2) Composition according to claim (1) characterized in that the liquid based on ethyl alcohol is ethanol type CH3CH2OH, C2H5OH .. anhydrous medical grade used in anesthesia, injected at a very low temperature. 3) Composition selon la revendication (2) caractérisée en ce que le liquide 10 puisse être d'origine naturel , à base de betterave rouge , grenade cassis , polyphénols , ..ou d'origine de synthèse dopé avec des éléments actifs de chimiothérapie , cytokines , agents cytotoxiques ou équivalents3) Composition according to claim 2, characterized in that the liquid may be of natural origin, based on beetroot, blackcurrant pomegranate, polyphenols, or of synthetic origin doped with active elements of chemotherapy, cytokines, cytotoxic agents or the like
FR1401580A 2014-07-04 2014-07-04 DEVICE APPLYING A NEW TECHNIQUE FOR TREATING BACTERIAL FIREFIGHTER WITH TWO SIMULTANEOUSLY APPLIED THERMAL ENTHALPY ABSORPTIONS AND DEHYDRATION Pending FR3023165A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1401580A FR3023165A1 (en) 2014-07-04 2014-07-04 DEVICE APPLYING A NEW TECHNIQUE FOR TREATING BACTERIAL FIREFIGHTER WITH TWO SIMULTANEOUSLY APPLIED THERMAL ENTHALPY ABSORPTIONS AND DEHYDRATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1401580A FR3023165A1 (en) 2014-07-04 2014-07-04 DEVICE APPLYING A NEW TECHNIQUE FOR TREATING BACTERIAL FIREFIGHTER WITH TWO SIMULTANEOUSLY APPLIED THERMAL ENTHALPY ABSORPTIONS AND DEHYDRATION

Publications (1)

Publication Number Publication Date
FR3023165A1 true FR3023165A1 (en) 2016-01-08

Family

ID=51982616

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1401580A Pending FR3023165A1 (en) 2014-07-04 2014-07-04 DEVICE APPLYING A NEW TECHNIQUE FOR TREATING BACTERIAL FIREFIGHTER WITH TWO SIMULTANEOUSLY APPLIED THERMAL ENTHALPY ABSORPTIONS AND DEHYDRATION

Country Status (1)

Country Link
FR (1) FR3023165A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505182A1 (en) * 1981-05-07 1982-11-12 Battentier Eric Treatment of external-internal cancers, scirrhous and verrucous states - by injection of an ethanol, salicylic acid and hydrogen peroxide liquid, followed by a pomade of celandine plant, copper sulphate etc.
EP2153838A1 (en) * 2007-06-12 2010-02-17 Hiroshima University Anti-norovirus agent, and composition comprising the same
CN101947203A (en) * 2010-10-14 2011-01-19 郑州后羿制药有限公司 Valnemulin hydrochloride emulsion for animals and preparation method thereof
US20130078288A1 (en) * 2007-11-21 2013-03-28 Chun Ho Yu Method of Treating Cancer

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505182A1 (en) * 1981-05-07 1982-11-12 Battentier Eric Treatment of external-internal cancers, scirrhous and verrucous states - by injection of an ethanol, salicylic acid and hydrogen peroxide liquid, followed by a pomade of celandine plant, copper sulphate etc.
EP2153838A1 (en) * 2007-06-12 2010-02-17 Hiroshima University Anti-norovirus agent, and composition comprising the same
US20130078288A1 (en) * 2007-11-21 2013-03-28 Chun Ho Yu Method of Treating Cancer
CN101947203A (en) * 2010-10-14 2011-01-19 郑州后羿制药有限公司 Valnemulin hydrochloride emulsion for animals and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EBARA M ET AL: "Percutaneous ethanol injection for small hepatocellular carcinoma: Therapeutic efficacy based on 20-year observation", JOURNAL OF HEPATOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 43, no. 3, 1 September 2005 (2005-09-01), pages 458 - 464, XP027780366, ISSN: 0168-8278, [retrieved on 20050901] *
KAMPF GÃ 1/4 NTER ET AL: "Comprehensive bactericidal activity of an ethanol-based hand gel in 15 seconds", ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, BIOMED CENTRAL, LPNDON, GB, vol. 7, no. 1, 22 January 2008 (2008-01-22), pages 2, XP021036838, ISSN: 1476-0711 *
WILLIAM M. HAYNES: "CRC Handbook of Chemistry and Physics, 95th Edition", 4 June 2014, CRC PRESS, article "Laboratory solvents and other liquid reagents", pages: 15-13 - 15-22, XP002735266 *

Similar Documents

Publication Publication Date Title
Erinjeri et al. Cryoablation: mechanism of action and devices
US6032675A (en) Freezing method for controlled removal of fatty tissue by liposuction
Baust et al. Mechanisms of cryoablation: clinical consequences on malignant tumors
Gage et al. Cryosurgery-a review of recent advances and current issues
Yu et al. Selective freezing of target biological tissues after injection of solutions with specific thermal properties
Yasuda Management of the bile duct stone: current situation in Japan
Cinman et al. Lasers in percutaneous renal procedures
Baust et al. Mechanisms of tissue injury in cryosurgery
FR3023165A1 (en) DEVICE APPLYING A NEW TECHNIQUE FOR TREATING BACTERIAL FIREFIGHTER WITH TWO SIMULTANEOUSLY APPLIED THERMAL ENTHALPY ABSORPTIONS AND DEHYDRATION
Hruby et al. Risk factors associated with renal parenchymal fracture during laparoscopic cryoablation
Liu et al. Laparoscopic transcystic treatment biliary calculi by laser lithotripsy
CN100502799C (en) Diaphragming air bag for ablation treatment
Abreu et al. Renal cell carcinoma: modern surgical approach
Yoo Laparoscopic colorectal surgery
Di Giacomo et al. Local adjuvants in surgical management of bone lesions
Baust et al. Evaluation of a novel cystoscopic compatible cryocatheter for the treatment of Bladder Cancer
Baust et al. Principles of cryoablation
CN200998309Y (en) Melting treatment obstructing gasbag
Kaplan et al. Cryogenic, Electrocoagulatiye and Spontaneous Necrosis of A bladder Neoplasm: A Preliminary Comparative Study
Forté et al. Anchoring the snare tip using a small incision in the submucosa facilitates en bloc endoscopic mucosal resection for sporadic duodenal adenomas
CN209713074U (en) With the puncture drainage component of the mating treatment polycystic liver and kidney of microwave melt needle
FR3000378A1 (en) Device for destroying cancerous tumor and recurrent bacteria by injecting e.g. cryogenic liquid, in extensible envelope into diseased area, has threaded duct for supply of fluid, and tube sliding around another tube according to travel
Schmidlin et al. Laser lithotripsy with the Ho: YAG laser: Fragmentation process revealed by time-resolved imaging
Colella et al. Cryotherapy: application in the airways
Kartha et al. Tissue‐Preserving Surgical Approaches in Urologic Oncology: The Therapeutic Mechanism for Tumor Ablation

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160108

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4